Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hricak

Showing results (531-540 of 565) with videos related to

Pageof 57
Sort By:
European Urology Oncology|June 18, 2019
Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled TrialsSungmin Woo, Chong Hyun Suh, James A Eastham, et al.
JAMA Oncology|May 15, 2020
Clinical Application of Computational Methods in Precision Oncology: A ReviewOrestis A Panagiotou, Lori Hoffman Högg, Hedvig Hricak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomyZohar A Dotan, Fernando J Bianco, Farhang Rabbani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter GenePeter Brader, Kaitlyn J Kelly, Nanhai Chen, et al.
European Urology Oncology|April 25, 2019
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate CancerKarim A Touijer, Laure Michaud, Herbert A Vargas Alvarez, et al.
The Lancet. Oncology|August 8, 2020
The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysisZachary J Ward, Surbhi Grover, Andrew M Scott, et al.
The American Journal of Pathology|October 23, 2016
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor SignalingAmita Shukla-Dave, Mireia Castillo-Martin, Ming Chen, et al.
Magnetic Resonance in Medicine|July 10, 2001
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imagingU G Mueller-Lisse, M G Swanson, D B Vigneron, et al.
Radiology|August 26, 2009
Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volumeYousef Mazaheri, Hedvig Hricak, Samson W Fine, et al.
European Radiology|December 7, 2016
Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture AnalysisYulia Lakhman, Harini Veeraraghavan, Joshua Chaim, et al.
Pageof 57

Showing results (531-540 of 565) with videos related to

Sort By:
Pageof 57
European Urology Oncology|June 18, 2019
Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled TrialsSungmin Woo, Chong Hyun Suh, James A Eastham, et al.
JAMA Oncology|May 15, 2020
Clinical Application of Computational Methods in Precision Oncology: A ReviewOrestis A Panagiotou, Lori Hoffman Högg, Hedvig Hricak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomyZohar A Dotan, Fernando J Bianco, Farhang Rabbani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter GenePeter Brader, Kaitlyn J Kelly, Nanhai Chen, et al.
European Urology Oncology|April 25, 2019
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate CancerKarim A Touijer, Laure Michaud, Herbert A Vargas Alvarez, et al.
The Lancet. Oncology|August 8, 2020
The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysisZachary J Ward, Surbhi Grover, Andrew M Scott, et al.
The American Journal of Pathology|October 23, 2016
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor SignalingAmita Shukla-Dave, Mireia Castillo-Martin, Ming Chen, et al.
Magnetic Resonance in Medicine|July 10, 2001
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imagingU G Mueller-Lisse, M G Swanson, D B Vigneron, et al.
Radiology|August 26, 2009
Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volumeYousef Mazaheri, Hedvig Hricak, Samson W Fine, et al.
European Radiology|December 7, 2016
Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture AnalysisYulia Lakhman, Harini Veeraraghavan, Joshua Chaim, et al.
Pageof 57